Tag: Rapanume

• Wednesday, July 31st 2013 - 17:59 UTC

  Pfizer agrees to pay 491m dollars to settle illegal marketing of Rapamune

  

  US drug-maker Pfizer has agreed to pay 491 million dollars to settle a probe into illegal marketing of a drug by Wyeth, a firm it had acquired in 2009. The case revolved around Rapamune, a drug prescribed to prevent rejection of transplanted kidneys.